About Pfizer Inc. 
Pfizer Inc.
Pharmaceuticals & Biotechnology
Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio includes medicines and vaccines. The Company manages its commercial operations through two business segments: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). IH focuses on developing and commercializing medicines and vaccines. IH therapeutic areas include internal medicine, vaccines, oncology, inflammation and immunology, rare diseases and consumer healthcare. EH includes legacy brands, branded generics, generic sterile injectable products, biosimilars and infusion systems. EH also includes a research and development (R&D) organization, as well as its contract manufacturing business. Its brands include Prevnar 13, Xeljanz, Eliquis, Lipitor, Celebrex, Pristiq and Viagra.
Company Coordinates 
Company Details
235 E 42ND ST , NEW YORK NY : 10017-5703
Registrar Details
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 264 Schemes (28.78%)
Foreign Institutions
Held by 651 Foreign Institutions (15.41%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
Dr. Albert Bourla
Chairman of the Board, Chief Executive Officer
Mr. Shantanu Narayen
Lead Independent Director
Dr. Susan Desmond-Hellmann
Director
Mr. Ronald Blaylock
Independent Director
Mr. Joseph Echevarria
Independent Director
Dr. Scott Gottlieb
Independent Director
Revenue and Profits:
Net Sales:
14,653 Million
(Quarterly Results - Jun 2025)
Net Profit:
2,903 Million
Pharmaceuticals & Biotechnology
USD 235,718 Million (Large Cap)
15.00
NA
409.58%
0.55
18.34%
2.66






